167 related articles for article (PubMed ID: 36086718)
1. Identification of an endoplasmic reticulum stress-associated gene signature to predict the immune status and prognosis of cutaneous melanoma.
Chen R; Niu L; Wu L; He Y; Liu G; Hong K
Medicine (Baltimore); 2022 Sep; 101(36):e30280. PubMed ID: 36086718
[TBL] [Abstract][Full Text] [Related]
2. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
3. Identification of a predictive gene signature related to pyroptosis for the prognosis of cutaneous melanoma.
Shi Z; Gu J; Yao Y; Wu Z
Medicine (Baltimore); 2022 Sep; 101(36):e30564. PubMed ID: 36086707
[TBL] [Abstract][Full Text] [Related]
4. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
5. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
6. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of drug sensitivity, immunological characteristics, and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatics and pan-cancer analysis.
Hounye AH; Hu B; Wang Z; Wang J; Cao C; Zhang J; Hou M; Qi M
J Mol Med (Berl); 2023 Oct; 101(10):1267-1287. PubMed ID: 37653150
[TBL] [Abstract][Full Text] [Related]
8. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
9. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
10. A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma.
Li AA; Li F; Lan M; Zhang Y; Xie D; Yan MY
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3227-3241. PubMed ID: 35687183
[TBL] [Abstract][Full Text] [Related]
11. A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma.
Wu Z; Chen L; Jin C; Xu J; Zhang X; Yao Y
PeerJ; 2021; 9():e12304. PubMed ID: 34721986
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
14. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
[TBL] [Abstract][Full Text] [Related]
15. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
Song Z; Su M; Li X; Xie J; Han F; Yao J
BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
He YW; Fan QP; Hua AL; Liu Q
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
[TBL] [Abstract][Full Text] [Related]
17. Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis.
Ren TY; Zhang YX; Hu W
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2927-2940. PubMed ID: 33877656
[TBL] [Abstract][Full Text] [Related]
18. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma.
Guo W; Wang X; Wang Y; Zhu S; Zhu R; Zhu L
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
